Twin Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Twin Capital Management's RMD Position: Q1 2026 in Review
Twin Capital Management reduced its ResMed (RMD) stake by 0.17% in Q1 2026, selling an estimated $1.5K and leaving 3,516 shares worth $789K. The position accounts for 0.1% of the portfolio, ranked #194.
Twin Capital Management first reported a position in RMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.47M in Q3 2018. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Twin Capital Management held 3,516 shares of ResMed worth $789K as of Q1 2026.
- Twin Capital Management sold 6 ResMed shares in Q1 2026, an estimated $1.5K.
- ResMed made up 0.1% of Twin Capital Management's portfolio in Q1 2026, its #194 holding.
- Twin Capital Management first reported a position in ResMed in Q2 2013 and has held it in 17 quarters since.
- Twin Capital Management's ResMed position peaked at $2.47M in Q3 2018.
- 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.